483R Document: Rentschler Biopharma SE, Feb 15, 2022

FDANews 483R Rentschler Biopharma SE Feb 15 2022 top
Wayne E. Seifert FDA Investigator

FDA inspected Rentschler Biopharma SE's Laupheim site on Feb 15, 2022. See how they responded.